The alert cites an incident affecting a cold room’s temperature recording system. Professionals are instructed to stop distributing, dispensing and using this batch, quarantine remaining stock and arrange returns with Pfizer.
Other batches are not affected. The published reason concerns temperature recording; it does not establish that the medicine itself experienced a temperature excursion. The notice also gives no duration for the incident or results from any product testing.